WHO ICTRP trial
Randomized study with stem cell transplantation versus standard treatment with…
EUCTR2017-001362-25-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001362-25-SE |
|---|---|
| Public title | Randomized study with stem cell transplantation versus standard treatment with alemtuzumab, cladribine or ocrelizumab in patients with relapsing remitting multiple sclerosis. |
| Scientific title | Randomized autologous hematopoietic stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab for patients with relapsing remitting Multiple Sclerosis - RAM-MS |
| Primary sponsor | Helse Bergen HF, Haukeland University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Denmark;Netherlands;Sweden |
| Conditions | Relapsing remitting multiple sclerosis. MedDRA version: 21.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C]… |
| Interventions | Trade Name: Sendoxane Product Name: Cyclophosphamide Pharmaceutical Form: Solvent for solution for infusion Trade Name: Thymoglobuline® Product Name: Thymoglobuline® Pharmaceutical Form: Powder for solution for infusion Trade Name: Lemtrada… |
| Registration date | Oct 17, 2017 |
| Target size | 100 |
| Secondary IDs | RAM-MS |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: